リファミシン抗生物質は,慢性支障管炎の治療に用いられる.

Evaluating surrogates for overall survival in the adjuvant treatment of bladder cancer with chemotherapy.

Urologic oncology·2025

Challenges and opportunities of predicting overall survival benefit from improvements to recurrence-free survival in stage II/III melanoma: a correlation meta-analysis.

Immuno-oncology technology·2025

A Psychological Study of Health, Injury, and Performance in Athletes on the US Alpine Ski Team.

The Physician and sportsmedicine·2016

Falsely incompatible B-cell flow cytometry crossmatch after pronase treatment: a case report.

Transplantation proceedings·2015

Assessing antibiotic therapy for Acinetobacter baumannii infections in an academic medical center.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2008

Defending against violence in hospitals.

Journal of healthcare protection management : publication of the International Association for Hospital Security·1999

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Design of solid phase microextraction patches for the detection of volatile metabolites associated with Burkholderia cepacia.

Applied microbiology and biotechnology·2026

Bacteremia evaluation with T2 magnetic resonance in the emergency room (BETTER).

Microbiology spectrum·2026

A Fatal Case of Clostridium septicum Mycotic Aortic Aneurysm: The Inadequacy of Thoracic Endovascular Aortic Repair in the Absence of Open Surgical Repair.

Cureus·2026

The power of ten: report from the 10th American Society for Microbiology Conference on Biofilms.

Journal of bacteriology·2026

Resistome, virulome and genomic insights into the silent dissemination of Acinetobacter baumannii during the COVID-19 pandemic in Brazil.

Frontiers in cellular and infection microbiology·2026

Correction: Presence of bacterial DNA in synovial fluid from the temporomandibular joint in patients with temporomandibular joint disorders.

Frontiers in oral health·2026

関連する実験動画

リファミシン抗生物質は,慢性支障管炎の治療に用いられる

関連する概念動画

Evaluating surrogates for overall survival in the adjuvant treatment of bladder cancer with chemotherapy.

Challenges and opportunities of predicting overall survival benefit from improvements to recurrence-free survival in stage II/III melanoma: a correlation meta-analysis.

A Psychological Study of Health, Injury, and Performance in Athletes on the US Alpine Ski Team.

Falsely incompatible B-cell flow cytometry crossmatch after pronase treatment: a case report.

Assessing antibiotic therapy for Acinetobacter baumannii infections in an academic medical center.

Defending against violence in hospitals.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Design of solid phase microextraction patches for the detection of volatile metabolites associated with Burkholderia cepacia.

Bacteremia evaluation with T2 magnetic resonance in the emergency room (BETTER).

A Fatal Case of Clostridium septicum Mycotic Aortic Aneurysm: The Inadequacy of Thoracic Endovascular Aortic Repair in the Absence of Open Surgical Repair.

The power of ten: report from the 10th American Society for Microbiology Conference on Biofilms.

Resistome, virulome and genomic insights into the silent dissemination of Acinetobacter baumannii during the COVID-19 pandemic in Brazil.

Correction: Presence of bacterial DNA in synovial fluid from the temporomandibular joint in patients with temporomandibular joint disorders.

関連する実験動画

リファミシン抗生物質は,慢性支障管炎の治療に用いられる

関連する概念動画

関連記事